Benzinga | Feb 2, 2021 06:33AM EST

IDEXX Laboratories Q4 EPS $2.01 Beats $1.40 Estimate, Sales $720.94M Beat $681.02M Estimate

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $2.01 per share which beat the analyst consensus estimate of $1.40 by 43.57 percent. This is a 93.27 percent increase over earnings of $1.04 per share from the same period last year. The company reported quarterly sales of $720.94 million which beat the analyst consensus estimate of $681.02 million by 5.86 percent. This is a 19.08 percent increase over sales of $605.45 million the same period last year.